Skip to content

Britannia Pharmaceuticals Ltd

A specialist pharmaceutical company in the STADA group focused on treatments for Parkinson's disease and other long-term neurological conditions.

Last updated September 11, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Britannia Pharmaceuticals Ltd is a specialist pharmaceutical company that operates as the global specialty centre for Parkinson's in the STADA Network. Founded in 1982 as a small, family-run business, it has pioneered the development and marketing of products for the treatment of Parkinson's since 1982 and for schizophrenia since 2004. As specialty partners in the STADA group, the company operates in over 30 countries worldwide.

History

Britannia Pharmaceuticals Ltd was founded in 1982 as a small, family-run business. Since 1982, Britannia has pioneered the development and marketing of products for the treatment of Parkinson's. Since 2004, Britannia has pioneered the development and marketing of products and services for the treatment of schizophrenia. The company has undergone impressive growth in the past 30 years and operates as the global specialty centre for Parkinson's in the STADA Network. As specialty partners in the STADA group, Britannia operates in over 30 countries worldwide.

Products and positioning

Specialty partners in the STADA group; global specialty centre for Parkinson's in the STADA Network.

Sources5 sources

Cite this profile: Cite the canonical profile. /brand-wiki/britannia-pharmaceuticals-ltd-united-kingdom · Editorial policy · How profiles are compiled